《新股消息》中康控股(02361.HK)明起招股 引入4名基投共投資1.3億元
健康洞察解決方案提供商中康控股(02361.HK)公布招股詳情,計劃全球發售7,500萬股,當中國際發售佔90%,本地公開發售佔10%,每股招股價介乎5.36至6.96元。
公司將於明日(28日)起招股,至下周二(7月5日)中午截止,計劃同日定價,預期將於7月12日掛牌,獨家保薦人為法國巴黎銀行。是次招股將引入百洋健康產業、Lun's Family Holdings、廣東康石壹號私募股權投資合夥企業及鄭靖杰為基石投資者,合共認購1.3億元等值股份,以發行中間價計算佔發行規模約28%。
集資所得預期約50.8%將用於升級及提升旗下SaaS產品及營銷推廣;約49.2%則計劃用於技術及數據倉庫進行進一步研發。
董事長兼首席執行官吳鬱抒表示,內地健康產業及健康大數據正在快速增長,醫療資源分配不均,加上人口老齡化,市場剛需無法得到滿足,因此看好行業未來發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.